Efficacy of once weekly teriparatide in patients with glucocorticoid-induced osteoporosis
Latest Information Update: 25 May 2021
At a glance
- Drugs Teriparatide (Primary) ; Alendronic acid
- Indications Corticosteroid-induced osteoporosis; Osteoporosis
- Focus Registrational; Therapeutic Use
- Acronyms TOWER-GO
- Sponsors Asahi Kasei Pharma Corp
- 01 May 2021 Results published in the Journal of Bone and Mineral Metabolism
- 22 Aug 2018 Status changed from active, no longer recruiting to completed.
- 04 Jan 2017 Planned number of patients changed from 400 to 204.